These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9921108)

  • 1. [Insulin sensitivity in NIDDM patients with normo- and microalbuminuria].
    Trzepióra B; Pokrzywnicki W; Zelechowski M
    Wiad Lek; 1998; 51(9-10):435-40. PubMed ID: 9921108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria in non-insulin dependent diabetes mellitus.
    Patel KL; Mhetras SB; Varthakavi PK; Merchant PC; Nihalani KD
    J Assoc Physicians India; 1999 Jun; 47(6):596-601. PubMed ID: 10999155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.
    Dinneen SF; Gerstein HC
    Arch Intern Med; 1997 Jul; 157(13):1413-8. PubMed ID: 9224218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in non-insulin-dependent diabetic patients with normo- and microalbuminuria.
    Gruden G; Veglio M; Cavallo-Perin P; Olivetti C; Mormile A; Cassader M; Pagano G
    Horm Metab Res; 1994 Oct; 26(10):489-90. PubMed ID: 7851875
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.
    Jensen JS
    Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Iwao T; Eto T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Curr Med Res Opin; 2008 Jun; 24(6):1561-7. PubMed ID: 18423105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors associated with microalbuminuria in non-hypertensive type-2 diabetes patients].
    López-Arce G; Espinoza-Peralta D; Hernández-Alarcón A; Arce-Salinas CA
    Rev Invest Clin; 2008; 60(1):4-10. PubMed ID: 18589581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of coronary risk factors in non-insulin dependent (type 2) diabetics.
    Walia M; Agarwal AK; Shah P; Yadav R; Singh CP; Yadav P
    J Assoc Physicians India; 1999 Nov; 47(11):1051-5. PubMed ID: 10862311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
    Kassab A; Ajmi T; Issaoui M; Chaeib L; Miled A; Hammami M
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):476-80. PubMed ID: 18753419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT prolongation in patients with Type 2 diabetes and microalbuminuria.
    Rutter MK; Viswanath S; McComb JM; Kesteven P; Marshall SM
    Clin Auton Res; 2002 Oct; 12(5):366-72. PubMed ID: 12420081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria is not associated with cardiovascular death in Japanese NIDDM.
    Araki S; Haneda M; Togawa M; Sugimoto T; Shikano T; Nakagawa T; Isono M; Hidaka H; Kikkawa R
    Diabetes Res Clin Pract; 1997 Feb; 35(1):35-40. PubMed ID: 9113473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microalbuminuria--a risk factor for diabetic nephropathy and cardiovascular disease].
    Pontuch P
    Vnitr Lek; 2001 May; 47(5):307-10. PubMed ID: 11395874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal.
    Sigdel M; Rajbhandari N; Basnet S; Nagila A; Basnet P; Tamrakar BK
    Nepal Med Coll J; 2008 Dec; 10(4):242-5. PubMed ID: 19558062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.